AcelRx Pharmaceuticals, Inc ACRX

nycblazer

ACRX has reached the lowest price @.46 a share, it has also double bottomed on the daily, the daily candle is bullish .. Looking to ride this buy for a long term. Going to ride it up to the red resistance trendline, if it becomes support it should reach $2 to $4. Happy New Year..

nycblazer

ACRX has reached the lowest price @.46 a share, it has also double bottomed on the daily, the daily candle is bullish.. Looking to ride this buy for a long term. Going to ride it up to the red resistance trendline, if it becomes support it should reach $2 to $4. Happy New Year..

CryptoFundManager Premium

ACRX AcelRx Pharmaceuticals is a specialty pharmaceutical company that focuses on the development and commercialization of therapies for the treatment of acute pain. 52 Week Range 0.65 - 2.94 Sitting at all time low now. HC Wainwright has a 5usd price target for it. My take profits are: 1: $0.95 2: $1.23 Stop loss: $0.57

UnknownUnicorn3570385

I feel like ACRX is bullish. It is biomed/growth stock season and this one has great technicals and price support. i bought a few.

DrewDimes

Entering here at 1.38. Feels like there's room to run upwards. Did some DD, and unlike many other pharmaceutical companies that get pumped and dumped, these guys actually have a legit product. High risk, high reward trade.

PlanTradePlanMM Pro

Hook Reversal In Demand Zone Entry 1.38 Stop 1.2 Target 2.25 I am not a PRO trader. I trade option to test my trading plan with small cost. The max Risk of each plan is less than 1% of my account. If you like this idea, please use SIM/Demo account to try it.

stvnschic

1-2 Year Hold, Break Even - Rapid Growth

EnisGuriGashi

In December AcelRx published clinical data in „The Journal of Universal Surgery“ titled „A Medication Use Evaluation of Sufentanil Sublingual Tablet 30 mcg for the Perioperative Management of Surgical Pain“. What is DSUVIA? According to AcelRx DSUVIA is a recently approved drug „indicated for use in adults in certified medically supervised healthcare settings for...

Syahmul

It broke its weekly resistance level and retesting it. Bullish sentiment in Daily and H4.

KozakHlib Premium

Contextual immersion trading strategy idea. AcelRx Pharmaceuticals is a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a...

shkspr

NASDAQ:ACRX Possible Scenario: LONG Evidence: Price Action This is my idea and could be wrong 100%

AlenCiken

This ACRX Penny Stock Could Surge Over 300%, Say Analysts AcelRx is a pharmaceutical company dedicated to the creation of safer treatments for acute pain, developing synthetic opioid drugs for sublingual (under the tongue) dosing. The company’s main product, Sufentanil, was approved by the FDA under the name Dsuvia in 2018, and by the EU as Dzuveo that same...

pantheo Pro+

C&H, Wedge

simplicitytrader Premium

NASDAQ:ACRX moved out of the weekly downtrend channel.

ssalman.uk

ACRX

PennyStock101 Premium

AcelRx Pharmaceuticals, Inc. is a pharmaceutical company focused on the development and commercialization of therapies for the treatment of moderate-to-severe acute pain. The Company operates through the segment, which includes development and commercialization of product candidates for the treatment of pain. Its lead product candidates include ARX-04, Zalviso,...

dobisa Premium

How about to play the second consolidation here?

scottg1018

ACRX - Long Seems a bit range bound and put in a nice bottom on the long trend line. Blew by the 8EMA and 20SMA and closed over the 50SMA after a blip below 30RSI at the lower part of the range. Big risk trade given the low price and rangy price action. SL set at 1.5xATR which is just below the long-term bottom of the range. ACRX - 500 Shares Entry - $2.71 SL -...